1-3 of 3
Sunitha Kakarla
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Preliminary Efficacy of "Ready to Administer" Cytomegalovirus (CMV)-Specific T Cells for the Treatment of Patients with Refractory CMV Infection

Ifigeneia Tzannou, MD, Kathryn S. Leung, Caridad Martinez, MD, Swati Naik, MD, Stephen Gottschalk, MD, Adrian P. Gee, PhD, Bambi Grilley, Ayumi Watanabe, Ann M. Leen, PhD, Sunitha Kakarla, PhD, Bilal Omer, MD
Journal: Blood
Blood (2016) 128 (22): 388.
https://doi.org/10.1182/blood.V128.22.388.388
Published: 2016
Journal Articles

T Cells Expressing Engager and Costimulatory Molecules for the Immunotherapy of CD19+ Malignancies

Mireya Paulina Velasquez, MD, Kota Iwahori, MD PhD, David L Torres, Sunitha Kakarla, PhD, Caroline Arber, MD, Tania Rodriguez-Cruz, PhD, Claudia Gerken, Xiao-Tong Song, PhD, Stephen Gottschalk, MD
Journal: Blood
Blood (2014) 124 (21): 2433.
https://doi.org/10.1182/blood.V124.21.2433.2433
Published: 2014
Journal Articles

T cells redirected against CD70 for the immunotherapy of CD70-positive malignancies

Donald R. Shaffer, Barbara Savoldo, Zhongzhen Yi, Kevin K. H. Chow, Sunitha Kakarla, David M. Spencer, Gianpietro Dotti, Meng-Fen Wu, Hao Liu, Shannon Kenney, Stephen Gottschalk
Journal: Blood
Blood (2011) 117 (16): 4304–4314.
https://doi.org/10.1182/blood-2010-04-278218
Published: 2011
Includes: Supplemental data